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Comparison of T1 Relaxation Times of the Neurochemical
Proﬁle in Rat Brain at 9.4 Tesla and 14.1 Tesla
Cristina Cudalbu,1* Vladimı´r Mlyna´rik,1 Lijing Xin,1 and Rolf Gruetter1–3
Knowledge of T1 relaxation times can be important for accurate
relative and absolute quantiﬁcation of brain metabolites, for
sensitivity optimizations, for characterizing molecular dynam-
ics, and for studying changes induced by various pathological
conditions. 1H T1 relaxation times of a series of brain metabo-
lites, including J-coupled ones, were determined using a pro-
gressive saturation (PS) technique that was validated with an
adiabatic inversion-recovery (IR) method. The 1H T1 relaxation
times of 16 functional groups of the neurochemical proﬁle were
measured at 14.1T and 9.4T. Overall, the T1 relaxation times
found at 14.1T were, within the experimental error, identical to
those at 9.4T. The T1s of some coupled spin resonances of the
neurochemical proﬁle were measured for the ﬁrst time (e.g.,
those of -aminobutyrate [GABA], aspartate [Asp], alanine
[Ala], phosphoethanolamine [PE], glutathione [GSH], N-acety-
laspartylglutamate [NAAG], and glutamine [Gln]). Our results
suggest that T1 does not increase substantially beyond 9.4T.
Furthermore, the similarity of T1 among the metabolites (1.5 s)
suggests that T1 relaxation time corrections for metabolite
quantiﬁcation are likely to be similar when using rapid pulsing
conditions. We therefore conclude that the putative T1 increase
of metabolites has a minimal impact on sensitivity when in-
creasing B0 beyond 9.4T. Magn Reson Med 62:862–867, 2009.
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Very high magnetic ﬁeld strengths (7T) are currently
available for in vivo studies on humans and animals. Stud-
ies at these very high magnetic ﬁelds beneﬁt from higher
signal-to-noise ratio (SNR) and increased spectral disper-
sion. Consequently, proton magnetic resonance spectros-
copy (MRS) became an important tool for noninvasively
investigating brain metabolism. At these magnetic ﬁelds,
knowledge of T1 relaxation times is important for accurate
relative and absolute quantiﬁcation of brain metabolites
when the repetition time is on the order of T1, such as in
quantitative spectroscopic imaging, for optimizing mea-
surement protocols, for characterizing molecular dynam-
ics, and for studying concentration changes induced by
various pathological conditions (1–3).
T1 relaxation times have been measured at 9.4T and
11.7T (1) for a few proton resonances, and a general trend
toward increased T1 has been observed with increasing
B0. This study and others (2,4–9) have focused on the
estimation of the T1 relaxation times of a few brain metab-
olites, mainly the singlets such as total choline, total cre-
atine (tCr), N-acetylaspartate(NAA)N-acetylaspartylgluta-
mate (NAAG), and in a very few cases the T1s of speciﬁc
coupled multiplets (inositol at 3.57 ppm or glutamate-
(Glu)glutamine (Gln) at 2.35 ppm). The quantiﬁcation of in
vivo short echo-time 1H MRS spectra is difﬁcult because of
overlaps between metabolite and macromolecule signals.
Therefore, previous studies have mainly been performed at
long TE values to minimize the contribution of macromole-
cule signals. At this long TE value, however, the J-coupled
spectral multiplets are generally distorted, thus making their
quantiﬁcation and the subsequent T1 estimation difﬁcult.
The most common techniques for measuring the T1 relax-
ation times of brain metabolites are inversion-recovery (IR)
(10) and progressive saturation (PS) (11). A drawback of the
IR method, compared to the PS technique, is the superposi-
tion of spectral lines with opposite signs due to the different
T1 of the metabolites, which may provide a complicated
spectral pattern. Thus, using the IR technique, primarily the
T1 relaxation times of singlets or of speciﬁc coupled multip-
lets (e.g., inositol at 3.57 or 3.65 ppm or Glu Gln at 2.35 or
3.75 ppm) were estimated.
With the availability of the ﬁrst 14.1T/26-cm MR system,
we recently implemented and assessed the performance of
ultrashort echo-time proton localized spectroscopy of rat
brain in vivo and demonstrated new spectral features at
14.1T (12) not seen previously at 9.4–11.7T.
Therefore, the goal of this study was to measure T1
relaxation times of proton signals, both singlets and J-
coupled multiplets, of rat brain metabolites and to deter-
mine whether T1 of the neurochemical proﬁle further in-
creases at 14.1T. For this reason we calculated T1 relax-
ation times of 16 components of the neurochemical proﬁle
at 9.4T and 14.1T in rat brain in vivo under identical
conditions using a PS technique (e.g., by varying TR) that
was validated with an adiabatic IR measurement for se-
lected metabolites.
METHODS
Animals
All animal experiments were conducted according to fed-
eral and local ethical guidelines and protocols were ap-
proved by the local regulatory body. In vivo experiments
were performed on adult female Sprague-Dawley rats (six
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animals at each magnetic ﬁeld; 250 g) that were anesthe-
tized during the experiments with 1.5% to 2.5% isoﬂurane
using a nose mask. Body temperature was maintained at
37.5  1.0°C by circulating warm water around the ani-
mals.
MRS Measurements
All data were acquired under identical conditions using
two MR instruments from Varian (Palo Alto, CA, USA): an
INOVA spectrometer interfaced to a 9.4T, actively-
shielded magnet with a 31-cm horizontal bore, and an MRI
System interfaced to a 14.1T magnet with a 26-cm hori-
zontal bore (both magnets from Magnex Scientiﬁc, Oxford,
UK). The magnets were equipped with 12-cm inner-diam-
eter actively-shielded gradient sets with a maximum gra-
dient of 400 mT/m in 120 s. Home-built 14-mm-diameter
1H quadrature surface coils were used as transceivers.
Eddy currents were minimized using time-dependent
quantitative eddy-current ﬁeld mapping (13). The static
ﬁeld homogeneity was adjusted using ﬁrst- and second-
order shims using an echo planar imaging (EPI) version of
FASTMAP (14). Localizer images were obtained in the
coronal planes using a multislice fast spin echo protocol
with TE/TR 60 ms/5000 ms, slice thickness 1 mm, and
in plane resolution  94 m. Spectra were obtained by an
ultrashort echo time (TE/TR  2.8 ms/4000 ms, complex
data points  4096, SW  7 kHz, 320 averages at 9.4T and
160 averages at 14.1T) spin-echo full-intensity acquired
localization (SPECIAL) technique (12,15). The size of the
voxel for 1H MRS was 3  4  5 mm3 including frontal
cortex, corpus callosum, and striatum. The reproducibility
of the voxel placement was based on anatomical land-
marks. The voxel was positioned 0.3 mm posterior to
bregma and 3.4 mm ventral. Identical radio frequency (RF)
pulses, gradient amplitudes, and sequence timing were
used on both instruments. After ﬁrst- and second-order
shimming, the typical linewidth of water resonance at
TE  2.8 ms was 12–14 Hz at 9.4T and 18–20 Hz at 14.1T.
Water signal was suppressed by a series of seven 25-ms
asymmetric variable-power RF pulses with optimized re-
laxation delays (VAPOR) (16). The water-suppression
pulses were interleaved with three modules of outer vol-
ume saturation, as described elsewhere (16). To compen-
sate for the magnetic ﬁeld drift, spectra were collected in
blocks of 16 averages that were stored separately in the
memory and were corrected for the relative shift in fre-
quency.
T1 measurements were accomplished using a PS tech-
nique (by changing TR in the range from 1 s to 10 s, nine
measurements, TE  2.8 ms) that was validated with an
adiabatic IR experiment for selected resonances. For the IR
measurements, the SPECIAL sequence was extended with
a 2-ms nonselective adiabatic inversion pulse (a band-
width  10 kHz), which was applied before starting the
localization part of the sequence. TI was varied in the
range from 0.1 to 1.8 s and a fully-relaxed spectrum was
obtained to determine equilibrium magnetization values at
TE  20 ms for selected metabolites. To eliminate the
effect of partial saturation, the spectra with different TIs
were collected with the same relaxation delay. The TE was
chosen to be 20 ms in order to partially eliminate the
contribution of macromolecule resonances, thus making
the quantiﬁcation of the IR time series more accurate.
Data Analysis
The PS series were analyzed using LCModel (17), com-
bined with a simulated basis-set of metabolites containing
the spectrum of macromolecules measured in vivo as de-
scribed previously (6,12). Other than the experimentally
measured macromolecule spectrum, the basis set at both
magnetic ﬁelds was created by quantum mechanics simu-
lations, based on the density-matrix formalism (18), using
published values of J-coupling constants and chemical
shifts (19). To obtain individual T1s of different groups in
the same molecule, the basis sets contained separate spec-
tra of acetyl and aspartyl moieties of NAA, and signals of
the CH3 and CH2 groups of tCr. The Crame´r-Rao lower
bounds (CRLBs) were calculated by LCModel as a measure
of the reliability of the metabolite estimates. The T1 relax-
ation times were estimated for the following functional
16 groups of metabolites: tCr at 3.03 ppm (CrPCr), the
methylene resonances of tCr (CrPCr*), the NAA acetyl
moiety (NAA), the aspartyl resonance of NAA (NAA*),
taurine (Tau), total choline (Cho), Glu, Gln, myoinositol
(Ins), alanine (Ala), aspartate (Asp), -aminobutyrate
(GABA), glutathione (GSH), NAAG, phosphoethanolamine
(PE), and macromolecules (Mac). The T1 for Glc and Lac
were not estimated due to their dependence on animal
physiology, such as anesthesia and glycemia.
The IR measurement was evaluated using the jMrui soft-
ware (available online at http://www.mrui.uab.es/mrui).
No water removal was performed as a preprocessing step.
The signals were ﬁtted using the “advanced method for
accurate, robust, and efﬁcient spectral” ﬁtting (AMARES)
(20). For quantiﬁcation purposes, the in vivo data were
Lorentzian line broadened with 20 Hz. For each in vivo
signal of the time-series, 13 Lorentzian spectral compo-
nents were selected to ﬁt the major contributions of the
metabolites, the zero-order phase was estimated and the
ﬁrst-order phase was ﬁxed to zero. The individual phases
relative to the zero-order phase were ﬁxed to zero or to
180° depending on the inversion time. Linewidths were
constrained to a predetermined interval. To minimize the
inﬂuence of the large broad baseline components linked to
the macromolecule resonances, the ﬁrst 20 data points of
the in vivo signals were weighted with a quarter-sine
wave. Thus the T1 relaxation times of macromolecules
were not reliably estimated. The accuracy of the amplitude
estimates was assessed using the CRLBs (21). The T1 re-
laxation times were estimated for the following spectral
lines: the singlet of N-acetylaspartate and NAAG at
2.01 ppm [NAA]; two lines of a triplet of glutamate at
2.35 ppm [Glu(2.35)]; singlets of tCr at 3.03 ppm [CrPCr]
and choline-containing compounds at 3.22 ppm [Cho]; the
triplet of Tau at 3.42 ppm (Tau); spectral lines of myoi-
nositol at 3.57 ppm [Ins(3.57)], 3.65 ppm [Ins(3.65)], and
4.05 ppm [Ins(4.05)]; a broader signal of Gln and Glu at
3.75 ppm [Glx (3.75)]; and a singlet of tCr at 3.92 ppm
[CrPCr*].
The T1 relaxation curves were ﬁtted with nonweighted
two-parameter single-exponential functions based on a
Levenberg-Marquardt algorithm, ﬁtting the M(0) and T1 for
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the IR series and equilibrium magnetization and T1 for the
PS series. For each ﬁt, the correlation coefﬁcients reﬂect-
ing the quality of the least squares ﬁt vs. the original data
were computed. A typical standard error of the ﬁtted T1
was about 5%.
To evaluate any possible increase of T1 at 14.1T, the
differences between the mean T1 relaxation time estimates
at 14.1T and 9.4T and the corresponding standard errors
(with P-values) were computed for each metabolite. In
addition, the T1 estimates obtained at both magnetic ﬁelds
were statistically compared using an unpaired two-tailed
Student’s t-test.
RESULTS
In general, spectra exhibited excellent SNR (Fig. 1) using
the IR approach. Notable differences in T1, such as of
CrPCr*, Tau, NAA, and Mac, were discernable with
varying TI. As can be seen in Fig. 1, the shorter times of
zero crossing were 0.42 s for Mac and  0.6 s for
CrPCr*, whereas NAA and Tau had longer zero-crossing
times, 1 s and 1.2 s, respectively. The T1 relaxation
times (mean SD) of 10 components of the neurochemical
proﬁle obtained using the IR technique at 9.4T and 14.1T,
are shown in Fig. 2. The measured amplitudes of the 10
selected metabolites showed excellent agreement with the
best ﬁts (Fig. 1). The corresponding CRLBs of the ampli-
tude estimates were below 20% for all 10 evaluated com-
pounds. The T1 were in a relatively narrow range from
1.2 s to 1.5 s for all metabolites. The notable exceptions
were Tau (2.2 s at both magnetic ﬁelds) and the methyl-
ene resonance of CrPCr (1 s at both magnetic ﬁelds).
The SDs of the T1 relaxation times calculated from six
animals were between 2% and 10% for most metabolites.
The correlation coefﬁcients reﬂecting the quality of the
least squares ﬁt vs. the original data were between 0.91 and
0.99. Using the IR method, the T1 measured at 14.1T were,
within the experimental error, identical to those measured
at 9.4T for most metabolites (Fig. 2). NAA was the only
metabolite that showed a statistically signiﬁcant increase
(P  0.004) with increasing B0. The difference between the
mean T1 estimates at 14.1T and 9.4T was only 8% (with
P  0.001) for NAA, whereas for the other metabolites this
difference was between 0.0 and 0.09 s and it was not
statistically signiﬁcant.
As with the IR technique, spectra acquired using the PS
technique exhibited excellent SNR (Fig. 3). Differences in
T1 between metabolites were also discernible in these se-
ries of spectra. As can be seen in Fig. 3, the amplitudes of
NAA, Cho, CrPCr, and particularly Tau dropped down
substantially at TR 1 s compared with TR 4 s, whereas
the decrease of amplitudes of CrPCr* and NAA* was
relatively small and there was no change in the amplitude
FIG. 1. a: Coronal view of a rat
brain showing a typical position of
a volume of interest. One series of
in vivo spectra acquired at 14.1T
in the rat brain with different inver-
sion times (TI), ranging from 0 to
1.8 s, and TE  20 ms (b) and the
corresponding estimates using
AMARES (c). For quantiﬁcation
purpose the in vivo data were
Lorentzian line-broadened with
20 Hz. No preprocessing for wa-
ter signal removal was applied.
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of the Mac signals in the range of 0.9 ppm to 1.8 ppm.
When using the progressive saturation technique in com-
bination with LCModel (Fig. 3), the high spectral resolu-
tion and sensitivity allowed the estimation of T1s for 16
metabolites or their speciﬁc functional groups, as demon-
strated by the good agreement between the in vivo data
and the best ﬁts. The precision of the metabolite quantiﬁ-
cation was assessed using the CRLBs obtained from the
LCModel analysis. The CRLBs of singlets and coupled
resonances of highly concentrated metabolites such as Cr,
NAA, Glu, Ins, and Tau were below 5% at 9.4T and 14.1T.
For metabolites such as Gln, GABA, Ala, Asp, NAAG, PE,
GSH, which are present at lower concentration and also
suffer from large overlap with other resonances, the CRLBs
were below 20% at both magnetic ﬁelds. Overall, the high
spectral resolution and SNR afforded at both magnetic
ﬁelds allowed the estimation of the T1 for the 16 compo-
nents of the neurochemical proﬁle which had CRLBs 	
20%. At both magnetic ﬁelds, the T1 relaxation times were
found in a relatively narrow range from 1.4 s to 1.9 s for all
metabolites, except for Tau (2.6 s at both magnetic ﬁelds)
(Fig. 4). The aspartyl resonance of NAA (NAA*) and meth-
ylene resonance of CrPCr had shorter T1 (1.2 s for
NAA* and 1.1 s for CrPCr* at both magnetic ﬁelds)
than the corresponding methyl resonances. As in previous
studies, the macromolecules had a markedly shorter T1
(0.66  0.07 s at 14.1T and 0.51  0.07 s at 9.4T). The SDs
of the T1 estimates were between 1% and 10% for most
metabolites. Figure 5 displays examples of the monoexpo-
nential ﬁttings of the in vivo Gln, NAA, NAA*, Tau, Asp
amplitude evolutions at 14.1T and 9.4T, respectively. The
correlation coefﬁcients were between 0.91 and 0.99 at both
magnetic ﬁelds. Overall, the T1 measured at 14.1T were
within the experimental error the same as those at 9.4T
(Fig. 4). NAA and Mac were the only metabolites that
showed a statistically signiﬁcant increase (P  0.001 for
NAA and P 0.007 for Mac). Like for the IR technique, the
difference between the mean T1 estimates at 14.1T and
9.4T was only 11% (with P  0.001) for NAA, whereas for
the other metabolites the difference was between 0.01 s
and 0.06 s and was not statistically signiﬁcant.
The T1 relaxation times obtained with the two methods
were the same within 15% (Figs. 2 and 4). At both
magnetic ﬁelds, the T1 values of some metabolites
(CrPCr, CrPCr*, NAA, and Tau) obtained by the PS
technique appeared to be slightly higher (P  0.001) com-
pared to those measured by the IR technique.
DISCUSSION
This study reports in vivo T1 relaxation times of singlets as
well as coupled spin resonances of 16 cerebral metabolites
at 9.4T and 14.1T, including for the ﬁrst time the T1s of
GABA, Asp, Ala, PE, GSH, NAAG, and Gln. The high
spectral resolution and sensitivity allowed the estimation
of 1H T1s of 16 metabolites using the progressive saturation
FIG. 2. T1 relaxation times (mean 
SD) of 10 resonances of the neuro-
chemical proﬁle estimated at 14.1T
(light bars) and 9.4T (black bars) in
the rat brain using the IR technique.
*Methylene resonance.
FIG. 3. One series of in vivo spectra acquired at 14.1T in the rat
brain with different repetition times (TR) and TE 2.8 ms (a) and the
corresponding estimates using LCModel (b). A shifted Gaussian
function exp[
(t 
 0.04)2/0.082] was used for modest resolution
enhancement. No baseline correction or preprocessing for water
signal removal was applied.
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approach, that were in excellent agreement with those
obtained by IR for selected metabolites.
The IR spectra with intermediate TIs exhibit a superpo-
sition of spectral lines with opposite phases due to the
different T1 of the metabolites, which provides a very
complicated spectral pattern. Thus the IR spectra were
difﬁcult to analyze by LCModel. We therefore used AM-
ARES for the quantiﬁcation of selected IR time series sig-
nals. The amplitudes of the 10 selected metabolites were
successfully estimated using AMARES for all the time
series of signals as demonstrated by the excellent agree-
ment between the in vivo data and the estimated data (Fig.
1c). The T1s of speciﬁc coupled multiplets (glutamate at
2.35 ppm; taurine at 3.42 ppm; spectral lines of myoinosi-
tol at 3.57 ppm, 3.65 ppm, and 4.05 ppm; and Gln and
glutamate at 3.75 ppm) are estimated and are not the T1s of
the whole metabolites as in the PS spectra. The SDs of the
T1 estimates using the IR technique were not signiﬁcantly
different for the two magnetic ﬁelds.
As with the IR technique, the SDs of the T1 relaxation
times calculated from six animals using the progressive
saturation approach were not signiﬁcantly different for the
two magnetic ﬁelds. However, a slight decrease of the SDs
was noticed at 14.1T despite the number of averages at
9.4T being two times higher than at 14.1T.
Our results showed a slight increase in the T1 relaxation
times using the PS technique compared with the IR one. It
is well known that the accuracy of the relaxation time
estimates also depends on the accuracy of the quantiﬁca-
tion of the spectral lines. Thus, it is very likely that the
differences between the T1s obtained with the two ap-
proaches are probably due to the different algorithms used
to quantify the metabolites. The two software packages
used in this study present their own characteristics
(17,20,22). Brieﬂy, in LCModel the metabolite basis set
represents the prior knowledge, whereas in AMARES the
prior knowledge is introduced by the user. Additionally,
the two quantiﬁcation methods handled the macromole-
cule contributions differently. For LCModel an in vivo
measured macromolecule spectrum was used, whereas for
AMARES the ﬁrst data points of the in vivo signals were
weighted. Another possible explanation of the differences
between the T1 relaxation times obtained with the two
techniques can be related to imperfect pulse ﬂip angles.
Indeed, the IR technique is less sensitive to pulse imper-
fections and the adiabatic hyperbolic secant RF pulse
FIG. 4. T1 relaxation times (mean  SD) of 16 components of the neurochemical proﬁle estimated at 14.1T (light bars) and 9.4T (black bars) in
the rat brain using the progressive saturation technique and LCModel analysis of the indicated spin systems. *Methylene and aspartyl resonances.
FIG. 5. Monoexponential ﬁtting (line) of the in vivo amplitude evolutions of Gln ({), NAA (‚), NAA* (), Tau (E), Asp (–) at 14.1T (left part)
and 9.4T (right part) in the rat brain for the T1 estimations using the progressive saturation technique. The estimated amplitudes (dots) are
drawn as a function of the repetition times (TR). For the presented ﬁts the correlation coefﬁcients were between 0.96 and 0.99.
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added prior to the SPECIAL sequence gives a perfect in-
version. The PS technique combined with the surface coils
is sensitive to the imperfect ﬂip angle setting, causing a
systematic bias of the calculated T1 relaxation times (11).
Simulations show that the calibration using slice-selective
RF pulses based on the maximum amplitude of the ac-
quired signal provides slightly overestimated RF pulse ﬂip
angles, which in turn leads to longer calculated T1 values.
Nevertheless, the T1 relaxation times obtained using the
IR method were the same within 15% of those obtained
using the PS techniques. Such a consistency can be taken
as a validation. For quantiﬁcation, where TR  T1, such
small variations in T1 are unlikely to have a substantial
impact on the derived concentrations.
The T1s obtained at 9.4T are very close to those obtained
for a small number of metabolites in previous studies at
9.4T and 11.7T in rats (1,6). At both magnetic ﬁelds, the
T1s were found in a relatively narrow range except for Tau.
The T1 values of NAA, CrPCr, and Cho obtained at 9.4T
using the IR method were in agreement with previous IR
studies at 9.4T (6). In particular, the high T1 of Tau was
consistent with another study (1). Interestingly, the aspar-
tyl resonance of NAA (NAA*) had shorter T1 than the
corresponding methyl resonances. Likewise, the T1 of the
methylene resonance of CrPCr (CrPCr*) in our study
was shorter and in agreement with previous works
(1,2,6,7).
A previous study (1) reported the T1 relaxation times of
seven components of brain metabolites plus the macro-
molecules at 4.7T, 9.4T, and 11.7T. Taking these seven
components from our T1 relaxation times of 16 compo-
nents of the neurochemical proﬁle obtained at 9.4T and
14.1T we noted good agreement with the values reported
in that study at 11.7T, suggesting that T1s do not increase
substantially beyond 9.4T. For example, the T1 of Mac
measured in our study was 0.66  0.07 s, whereas the T1
reported at 11.7T was between 0.62 s and 0.76 s. For most
other metabolites, the T1s obtained in our study were,
within the experimental errors, in agreement with the
values reported at 11.7T (1). It is interesting to note that
Cho had a slightly shorter T1 (20%) in our study at 14.1T
than the T1 reported at 11.7T in Ref. 1. This difference
might be due to a complicated way of quantifying the
signal intensity of Cho in Ref. 1. However, while this
previous study suggested that T1 increases with B0, T1s at
14.1T were identical, within experimental errors, to those
at 9.4T (Figs. 2 and 4). Therefore, the relative narrow range
of T1s estimated in our study at both magnetic ﬁelds,
combined with the lack of a substantial increase at 14.1T,
indicate that at 14.1T the T1 relaxation time corrections for
metabolite quantiﬁcation routines are likely to be similar
when using rapid pulsing conditions and some differential
corrections may be necessary for Tau and CrPCr*. Ac-
cording to the Ernst angle (23), if TR  2 s is used (in
spectroscopic imaging), providing the maximum SNR in a
given measurement time, the loss in sensitivity for Tau
will then be 23%.
In summary, we measured for the ﬁrst time the T1 relax-
ation times of 16 components of the neurochemical proﬁle
using the PS method combined with LCModel. The ob-
tained T1 relaxation times at 14.1T were identical, within
the experimental error, to those at 9.4T. In addition, our T1
values are in good agreement with the published data at
9.4T and 11.7T and suggest that T1s do not increase sub-
stantially beyond 9.4T. We therefore conclude that the
putative T1 increase of metabolites has a minimal impact
on sensitivity when increasing B0 beyond 9.4T.
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